Chuan has developed a yeast-mediated platform for direct cloning and parallelizable editing of bacterial natural product biosynthetic gene clusters. He is currently focused on employing this platform to elucidate and engineer  the biosynthetic pathways of peptidyl α, β-epoxyketone proteasome inhibitors, with the aim of developing more sustainable routes for the production of drugs to treat  multiple myeloma. Outside of the lab, Chuan enjoys bouldering and hiking.